new glp 1 drugs coming GLP-1 from the Gray Market New GLP-1 Pills Are Coming,

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide (Ozempic/Wegovy) and liraglutide (Victoza/Saxenda) were built for diabetes and obesitybut theyre increasingly being studied for brain health and systemic inflammation.

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Underwriters are treating your clients' dramatic weight loss as a red flag, not a health victory

GLP-1 agonists are regularly prescribed by doctors for patients with Type 2 Diabetes. And now theyre the next big thing in the weight loss world.

A gastroenterologist can help manage symptoms and protect your digestive health while on GLP-1 therapy.

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.